KING OF PRUSSIA, Pa.--(EON: Enhanced Online News)--A session featuring a panel of key executives from Theorem Clinical Research, a leading global provider of clinical trial management services for complex, combination trials, will be offered at the Outsourcing in Clinical Trials Southern California conference at the Marriott San Diego in La Jolla, Calif., on Sept. 24.
“Exploring Whether Risk-Based Monitoring is Right for Your Study and Organization”
“Exploring Whether Risk-Based Monitoring is Right for Your Study and Organization” will feature Brian Bollwage, Theorem vice president of global regulatory affairs; Aimee Frazier, Theorem executive director of biopharmaceutical development; Mark Penniston, Theorem senior vice president and general manager of clinical analytics; and Alison Taber, Theorem vice president of global data management.
“Risk-based monitoring (RBM) is about connecting the dots among the regulatory landscape, the readiness for change at investigator sites and demands to conduct trials efficiently, but still having unquestioned data integrity,” Bollwage said. “This session will examine a more defined approach to data visualization, quality and risk mitigation in RBM.”
The conference is geared toward executives with responsibility for clinical outsourcing decisions within biotechnology, pharmaceutical, virtual and medical device companies throughout Southern California. Theorem will be exhibiting in booth #15.
“Exploring Whether Risk-Based Monitoring is Right for Your Study and Organization” will be held at 9:30 a.m. Tuesday, Sept. 24.
About Theorem Clinical Research
Theorem Clinical Research Inc. is a leading midsized provider of comprehensive clinical research and development services with offices in more than 30 countries and a customer base comprised of some of the world's top pharmaceutical, biotech and medical device companies. As a forerunner in medical device and drug-device combination trials with notable capabilities in pharmaceuticals and biologics, Theorem offers deep expertise in a broad range of therapeutic areas and in all phases of development. With some of the industry's top scientists and most advanced clinical analytics capabilities, Theorem ensures smooth-running, successful trials. For the full-service, right-size global research partner, don't think twice. THINK THEOREM.